$CBDW 1606 Corp. (CBDW) Announces Successful 10-Q Filing,

New Post Public Reply Private Reply Replies (0) Message Board
louied91
87
$CBDW 1606 Corp. (CBDW) Announces Successful 10-Q Filing, Increased Market Activity, and Active M&A Strategy


https://www.accessnewswire.com/newsroom/en/co...et-1060052

SEATTLE, WA / ACCESS Newswire / August 13, 2025 / 1606 Corp. (the "Company" (OTCID:CBDW) is pleased to announce the timely filing of its Quarterly Report on Form 10-Q for the second quarter of 2025. This filing highlights the Company's continued commitment to transparency, regulatory compliance, and delivering consistent shareholder updates. The Company believes these factors and its continued development make 1606 Corp. a valuable and sought after public entity in a great position for future growth.

As part of its forward-looking initiatives, 1606 Corp. is actively pursuing mergers and acquisitions that align with its long-term vision. The Company is currently evaluating several strategic opportunities designed to expand market presence, enhance capabilities, and create sustainable shareholder value.

The Company has timely filed our Quarterly Report on Form 10-Q for the second quarter of the year 2025. This filing reflects our ongoing commitment to transparency and regulatory compliance, providing detailed insights into our financial performance and operational activities. We are proud to have remained current with all SEC filings since our inception.

In addition to this regulatory achievement, 1606 Corp. has seen a significant increase in trading volume since its successful transition to the OTCID marketplace on July 1, 2025. We believe the increase in volume reflects rising investor interest and confidence in the Company's growth strategy.

"We are proud to maintain full SEC compliance while gaining meaningful traction in the market," said Austen Lambrecht, CEO of 1606 Corp. "We believe our ongoing pursuit of strategic acquisitions positions us well for scalable growth and continued momentum through the remainder of 2025 and beyond."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GEEKOM A5 2027: Mini PC Built to Boost Your Game

Updated Category News Views 1

GEEKOM Raises the Bar with A5 2027 Build Every once in a blue moon, a piece of tech pricks up my ears and this time it's the GEEKOM A5 2027 Edition. Released on September 7, 2026, this contraption's not just joining the ranks—it's looking to redefine them. It's geared for the real-world junkie who’s raking through browser tabs, dropping into video meetings, and making...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 4

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Lab Glassware Market Set for Steady Growth by 2031

Updated Category News Views 1

When you dive into the world of laboratory glassware, it might look like it's all pipettes and test tubes, but there's more bubbling under the surface. This market's got its eyes on a neat little climb from $7,630 million in 2026 to a forecasted $9,170 million by 2031. Ain't just speculation—this one's solid muscle growing at a comfortable 4.0% compound annual growth...

Continue Reading
CalExitNow Fights Federal Interference in CA Elections

Updated Category News Views 2

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

Continue Reading
Universal Music Wraps €250M Share Buyback Plan

Updated Category News Views 1

Universal's Encore Performance in the Markets Universal Music Group (EURONEXT: UMG), the behemoth in music-based entertainment, just wrapped up its €250 million share buyback program. Talk about a grand finale! In a week’s worth of maneuvering from August 31 to September 4, they snagged 294,340 of their own shares, all for the pretty price of €14.65 a pop. Grand...

Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating

Updated Category News Views 4

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Continue Reading
Withings and FFBB Team Up for Healthier Hoops

Updated Category News Views 3

Withings Joins Forces with French Basketball Elite When it comes to linking technology and sports, nothing quite shows promise like Withings teaming up with the French Basketball Federation (FFBB). Picture this: a French startup that's crafted its legacy on cutting-edge health tech now throws its lot in with a nation proud of its basketball prowess. It's the kind of...

Continue Reading
Regan Hutsell Shines as 99th Miss America Winner

Updated Category News Views 0

There's a buzz in the air that's hard to ignore—Regan Hutsell from Texas secured the legendary Miss America crown. This event isn't just another chapter in the pageant's nearly century-old saga, but it's a spotlight moment that nods to Miss America's long-enduring cultural resonance. Now, you might be wondering: With all eyes on this Texan, what ripples could she send...

Continue Reading
TECNO CAMON Slim 5G: Where Art Meets Tech

Updated Category News Views 1

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Continue Reading

Top 5 Most Recently Viewed Articles

Tevogen Bio Advocates for Long COVID Solutions on Capitol Hill

Updated Category News Views 70

Tevogen Bio Champions Long COVID Patient Advocacy Tevogen Bio, a clinical-stage biotech company specializing in immunotherapy, is drawing attention for its proactive stance on important healthcare challenges. Recently, the company has turned its focus to advocating for patients with Long COVID. This initiative gained prominence when Tevogen's leadership met with members...

Continue Reading
Rybelsus® Shows Promising Cardiovascular Benefits in SOUL Trial

Updated Category News Views 515

Rybelsus® Shows Significant Reduction in Cardiovascular Events Recent findings from the SOUL cardiovascular outcomes trial have highlighted the effectiveness of Rybelsus® (oral semaglutide) in significantly reducing the risk of major adverse cardiovascular events (MACE) among adults suffering from type 2 diabetes and associated conditions. Clinical data from the trial...

Continue Reading
Quipt Home Medical Reports Promising Q1 Fiscal 2025 Results

Updated Category News Views 312

Quipt Home Medical's Strong Start to Fiscal Year 2025 Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT), a prominent provider of home medical equipment with a focus on respiratory care, shared its financial results for the first quarter of fiscal year 2025, covering the three-month period ending December 31, 2024. Diligently reported in U.S. Dollars, these results...

Continue Reading
Argent BioPharma Secures $4.5 Million in Capital Raise

Updated Category News Views 147

Argent BioPharma's Successful Capital Raise and Future Prospects Argent BioPharma Limited (ASX: RGT) is a clinical-stage biopharmaceutical company that focuses on developing innovative treatments for central nervous system (CNS) and immune-related disorders through advanced nano-medicine technology and neuro-immune modulation. Recently, Argent BioPharma announced a...

Continue Reading
Bernie Sanders Highlights High Costs of Ozempic and Patient Impact

Updated Category News Views 56

Bernie Sanders Criticizes High Costs of Ozempic Senator Bernie Sanders has recently expressed his deep frustration over the soaring prices of Ozempic, a medication made by Novo Nordisk A/S (NYSE: NVO). While it’s primarily prescribed for managing diabetes, Ozempic has also become popular as a weight loss solution. Inconsistent Medication Prices In a fervent post on...

Continue Reading